Posts

Pharmacogenomics
, ,

Pharmacogenomics: Bridging the Innovation Gap in Drug Development

There is a saying in medicine: treat the patient, not the disease. This caveat is commonly preached to new medical residents as a reminder that holistic care is essential and that the same disease process in a different patient is essentially…
TruSeq Amplicon Cancer Panel

Benefits of TruSeq Amplicon – Cancer Panel In Cancer Research

The average prescription-grade drug takes a decade of research and billions of dollars in funding in order to reach the market. Combined with the rate at which new and rare diseases continue to be discovered, this leaves pharmaceutical companies…
Clinical Research Sequencing
, ,

Optimizing Drug Outcomes with Patients through Pharmacogenomics

In the United States, there are approximately 30 million individuals (~10%) living with a rare disease with no known modality. This isn't slowing down either with around 7,000 different types of rare diseases found each day. The unfortunate…
Next Generation Sequencing

The Myth of Whole Genome Sequencing

We talk with many pharmaceutical and healthcare providers who want to understand the world of "pharmacogenomics". Pharmacogenomics is the study of how genes affect a person's response to prescribed drugs. Today, we effectively create drugs for…